Nutriband files provisional patent application to enhance its AVERSA™ transdermal abuse deterrent technology being developed for patches containing opioids and stimulants with a potential for abuse.

VANCOUVER, British Columbia, Sept. 30, 2025 (GLOBE NEWSWIRE) -- via IBN -- Branded Legacy, Inc. (OTC: BLEG), a dynamic holding company focused on innovative life sciences and wellness solutions, is ...

SINGAPORE, Oct. 08, 2025 (GLOBE NEWSWIRE) -- ESGL Holdings Limited (NASDAQ: ESGL), a leading carbon neutral, innovative enviro-tech company regenerating industrial waste into circular products, ...

STAMFORD, Conn. — In The Car, LLC., an embedded digital-first insurance platform, today announced that it has filed a U.S. provisional patent application for its innovative technology that delivers ...

The U.S. Patent and Trademark Office (USPTO) published a Federal Register Notice today launching the Streamlined Claim Set ...

ORLANDO - Nutriband Inc. (NASDAQ:NTRB), a pharmaceutical company showing strong momentum with a 56.8% price return over the past six months according to InvestingPro data, announced Wednesday it has ...

Nutriband (NASDAQ: NTRB), a developer of prescription transdermal pharmaceutical products, announced the filing of a provisional patent application with the U.S. Patent and Trademark Office to expand ...

Delhi High Court held that seized amounts prima facie being proceeds of crime cannot be termed as income of accused as trial in PMLA case is yet to be conclude. Accordingly, it is erroneous to treat ...

Trust Stamp (Nasdaq: IDAI) announced that the United States Patent and Trademark Office (“USPTO”) has issued a notice of allowance in respect of Non-Provisional Patent Application No. 18/145,470 ...

U.S. Citizenship and Immigration Services Oct. 20 released updated guidance regarding the new $100,000 fee for H-1B visas ...